JAZZ vs. SMG

Last updated Jun 4, 2026

JAZZ (Jazz Pharmaceuticals plc) and SMG (The Scotts Miracle-Gro Company) are both stocks. JAZZ operates in Biotechnology (Healthcare), while SMG operates in Agricultural Inputs (Basic Materials). Over the past 10 years, JAZZ returned 4.22%/yr vs 1.19%/yr for SMG. At a 0.26 correlation, their price movements are largely independent.

Performance

JAZZ vs. SMG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Jazz Pharmaceuticals plc (JAZZ) and The Scotts Miracle-Gro Company (SMG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, JAZZ achieves a 35.84% return, which is significantly higher than SMG's -0.32% return. Over the past 10 years, JAZZ has outperformed SMG with an annualized return of 4.22%, while SMG has yielded a comparatively lower 1.19% annualized return.

JAZZ

• 1D: 2.13%
• 1M: 10.99%
• YTD: 35.84%
• 6M: 38.20%
• 1Y: 109.33%
• 3Y*: 21.63%
• 5Y*: 5.88%
• 10Y*: 4.22%

SMG

• 1D: 0.97%
• 1M: -3.00%
• YTD: -0.32%
• 6M: 2.87%
• 1Y: 3.33%
• 3Y*: -0.94%
• 5Y*: -19.32%
• 10Y*: 1.19%

*Multi-year figures are annualized to reflect compound growth (CAGR)

JAZZ vs. SMG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
JAZZ Jazz Pharmaceuticals plc	35.84%	38.04%	0.12%	-22.79%	25.05%	-22.81%	10.56%	20.43%	-7.94%	23.50%
SMG The Scotts Miracle-Gro Company	-0.32%	-8.01%	8.28%	36.92%	-68.81%	-18.03%	96.18%	77.05%	-41.00%	14.46%

Correlation

The correlation between JAZZ and SMG is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.19
Correlation (3Y) Calculated over the trailing 3-year period	0.26
Correlation (5Y) Calculated over the trailing 5-year period	0.27
Correlation (10Y) Calculated over the trailing 10-year period	0.26
Correlation (All Time) Calculated using the full available price history since Jun 4, 2007	0.26

Fundamentals

Market Cap JAZZ : $15.26B SMG : $3.37B
EPS JAZZ : $0.47 SMG : $1.90
PE Ratio JAZZ : 489.15 SMG : 29.96
PEG Ratio JAZZ : 31.80 SMG : 0.21
PS Ratio JAZZ : 3.25 SMG : 0.98
Total Revenue (TTM) JAZZ : $4.44B SMG : $3.39B
Gross Profit (TTM) JAZZ : $2.97B SMG : $1.10B
EBITDA (TTM) JAZZ : $336.83M SMG : $493.90M

Return for Risk

JAZZ vs. SMG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JAZZ

JAZZ Risk / Return Rank: 96
JAZZ Sharpe Ratio Rank: 94
JAZZ Sortino Ratio Rank: 96
JAZZ Omega Ratio Rank: 95
JAZZ Calmar Ratio Rank: 97
JAZZ Martin Ratio Rank: 96

SMG

SMG Risk / Return Rank: 41
SMG Sharpe Ratio Rank: 43
SMG Sortino Ratio Rank: 38
SMG Omega Ratio Rank: 38
SMG Calmar Ratio Rank: 43
SMG Martin Ratio Rank: 43

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JAZZ vs. SMG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Jazz Pharmaceuticals plc (JAZZ) and The Scotts Miracle-Gro Company (SMG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	JAZZ	SMG	Difference
Sharpe ratio Return per unit of total volatility	2.98	0.09	+2.89
Sortino ratio Return per unit of downside risk	4.54	0.39	+4.15
Omega ratio Gain probability vs. loss probability	1.57	1.05	+0.53
Calmar ratio Return relative to maximum drawdown	9.63	0.14	+9.49
Martin ratio Return relative to average drawdown	23.75	0.26	+23.49
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

JAZZ vs. SMG - Sharpe Ratio Comparison

The current JAZZ Sharpe Ratio is 2.98, which is higher than the SMG Sharpe Ratio of 0.09. The chart below compares the historical Sharpe Ratios of JAZZ and SMG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	JAZZ	SMG	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.98	0.09	+2.89
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.19	-0.42	+0.61
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.13	0.03	+0.10
Sharpe Ratio (All Time) Calculated using the full available price history	0.19	0.21	-0.02

Drawdowns

JAZZ vs. SMG - Drawdown Comparison

The maximum JAZZ drawdown since its inception was -96.90%, which is greater than SMG's maximum drawdown of -83.55%. Use the drawdown chart below to compare losses from any high point for JAZZ and SMG.

Drawdown Indicators

	JAZZ	SMG	Difference
Max Drawdown Largest peak-to-trough decline	-96.90%	-83.55%	-13.35%
Max Drawdown (1Y) Largest decline over 1 year	-11.42%	-23.85%	+12.43%
Max Drawdown (3Y) Largest decline over 3 years	-32.71%	-47.42%	+14.71%
Max Drawdown (5Y) Largest decline over 5 years	-47.55%	-79.89%	+32.34%
Max Drawdown (10Y) Largest decline over 10 years	-52.10%	-83.55%	+31.45%
Current Drawdown Current decline from peak	-3.71%	-72.67%	+68.96%
Average Drawdown Average peak-to-trough decline	-27.42%	-21.13%	-6.29%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.62%	13.05%	-8.43%

Volatility

JAZZ vs. SMG - Volatility Comparison

The current volatility for Jazz Pharmaceuticals plc (JAZZ) is 9.90%, while The Scotts Miracle-Gro Company (SMG) has a volatility of 10.78%. This indicates that JAZZ experiences smaller price fluctuations and is considered to be less risky than SMG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	JAZZ	SMG	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.90%	10.78%	-0.88%
Volatility (6M) Calculated over the trailing 6-month period	23.47%	26.71%	-3.24%
Volatility (1Y) Calculated over the trailing 1-year period	36.89%	35.74%	+1.15%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	31.75%	46.27%	-14.52%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	32.77%	40.38%	-7.61%

Dividends

JAZZ vs. SMG - Dividend Comparison

JAZZ has not paid dividends to shareholders, while SMG's dividend yield for the trailing twelve months is around 4.63%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
JAZZ Jazz Pharmaceuticals plc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SMG The Scotts Miracle-Gro Company	4.63%	4.52%	3.98%	4.14%	5.43%	1.59%	3.72%	2.13%	3.51%	1.93%	2.03%	2.85%

Financials

JAZZ vs. SMG - Profitability Comparison

The chart below illustrates the profitability comparison between Jazz Pharmaceuticals plc and The Scotts Miracle-Gro Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

JAZZ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Jazz Pharmaceuticals plc reported a gross profit of 0.00 and revenue of 1.07B. Therefore, the gross margin over that period was 0.0%.

SMG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Scotts Miracle-Gro Company reported a gross profit of 610.50M and revenue of 1.46B. Therefore, the gross margin over that period was 41.8%.

JAZZ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Jazz Pharmaceuticals plc reported an operating income of 336.60M and revenue of 1.07B, resulting in an operating margin of 31.5%.

SMG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Scotts Miracle-Gro Company reported an operating income of 401.80M and revenue of 1.46B, resulting in an operating margin of 27.5%.

JAZZ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Jazz Pharmaceuticals plc reported a net income of 293.10M and revenue of 1.07B, resulting in a net margin of 27.4%.

SMG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Scotts Miracle-Gro Company reported a net income of 238.60M and revenue of 1.46B, resulting in a net margin of 16.4%.

Frequently Asked Questions

Can I hold both JAZZ and SMG in my portfolio?

JAZZ and SMG have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, JAZZ or SMG?

SMG has higher volatility (10.78%) compared to JAZZ (9.90%). In terms of maximum drawdown, JAZZ dropped -96.90% vs SMG's -83.55%.

Which has better risk-adjusted returns?

JAZZ currently has the higher Sharpe Ratio (2.98 vs 0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.